molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles,pActivity
CHEMBL815,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4200.0,nM,CHEMBL767812,B,Affinity for Prostanoid EP4 receptor expressed in CHO cells,CHEMBL1132967,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,5.376750709602099
CHEMBL815,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4200.0,nM,CHEMBL767813,B,In vitro binding at EP4 human prostaglandin receptor using [3H]PGE-2 as radioligand,CHEMBL1134785,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O,5.376750709602099
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.7,nM,CHEMBL765917,B,Inhibitory activity against human EP4 receptor expressed in HEK293 ebna cells,CHEMBL1136653,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,9.154901959985743
CHEMBL275667,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.4,nM,CHEMBL767814,B,Inhibitory activity against human EP4 receptor expressed in HEK293 ebna cells,CHEMBL1136653,IC50,O=C1CC[C@H](/C=C/[C@@H](O)Cc2ccccc2)N1CCCCCCc1nnn[nH]1,8.853871964321762
CHEMBL231184,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,15848.93,nM,CHEMBL887240,B,Binding affinity to human EP4 receptor expressed in CHO cells,CHEMBL1144577,IC50,Cc1ccc(-n2c(C)ccc2-c2cc(Cl)ccc2OCc2ccc(F)cc2)cc1C(=O)O,4.800000052738446
CHEMBL427844,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,158.49,nM,CHEMBL890036,B,Inhibition of EP4 receptor,CHEMBL1146289,IC50,CC(=O)Nc1cc(C(=O)O)cc(-n2c(C)ccc2-c2cc(Br)ccc2OCc2ccc(F)cc2F)c1,6.799998134593398
CHEMBL400404,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,24000.0,nM,CHEMBL896001,B,Inhibition of human recombinant EP4 receptor expressed in 293EBNA cells,CHEMBL1148848,IC50,CC(=O)Nc1cccc(-c2ccc(Cc3ocnc3C(=O)N[C@@H](Cc3ccccc3)C(=O)O)cc2)c1,4.619788758288394
CHEMBL521609,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,12500.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc4ccccc4c3)cccc21,4.903089986991944
CHEMBL489310,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20400.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,4.690369832574102
CHEMBL459885,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,14600.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2ccc(F)c(F)c2)c2c(Oc3ccc(Cl)cc3Cl)cccc21,4.835647144215563
CHEMBL475348,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,13000.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(Cl)c3)cccc21,4.886056647693163
CHEMBL521777,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10000.0,nM,CHEMBL960019,B,Displacement of radioligand from EP4 receptor,CHEMBL1153263,IC50,Cn1cc(/C=C/C(=O)NS(=O)(=O)c2cc(F)c(F)cc2F)c2c(Oc3ccc(Cl)c(F)c3)cccc21,5.0
CHEMBL461571,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3700.0,nM,CHEMBL980761,B,Inhibition of prostanoid EP4 receptor,CHEMBL1139415,IC50,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1,5.431798275933005
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.8,nM,CHEMBL947374,B,Displacement of radiolabeled PGE2 from human prostanoid EP4 receptor,CHEMBL1140203,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.42021640338319
CHEMBL482330,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,7500.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,COc1cccc(CN2C(=O)CC3(C)CCCC(/C=C/C(=O)NS(=O)(=O)c4ccc(F)c(F)c4)=C23)c1,5.1249387366083
CHEMBL479664,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,7700.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3ccc(F)c(F)c3)=C1N(Cc1ccc(F)c(F)c1)C(=O)C2,5.113509274827518
CHEMBL482018,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20800.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1cccc(Cl)c1Cl)C(=O)C2,4.681936665037238
CHEMBL479439,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20800.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1ccc(Cl)cc1Cl)C(=O)C2,4.681936665037238
CHEMBL479263,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6200.0,nM,CHEMBL1023730,B,Binding affinity to human EP4 receptor by radioligand binding assay,CHEMBL1143334,IC50,CC12CCCC(/C=C/C(=O)NS(=O)(=O)c3cc(F)c(F)cc3F)=C1N(Cc1ccc(F)c(F)c1)C(=O)C2,5.207608310501746
CHEMBL565591,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8039.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,5.094797971337681
CHEMBL565992,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10172.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2ncn(Cc3ccc(Cl)cc3Cl)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,4.992593648496329
CHEMBL467632,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6498.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(COc1cccc2[nH]cc(Cc3ccc4ccccc4c3)c12)NS(=O)(=O)c1cc(Cl)c(Cl)s1,5.187220292991036
CHEMBL585581,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8178.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,O=C(/C=C/c1cccc2ccn(Cc3ccc(Cl)cc3Cl)c12)NS(=O)(=O)c1cccs1,5.0873528937816825
CHEMBL565799,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3647.0,nM,CHEMBL1045308,B,Displacement of [3H]PGE2 from human EP4 receptor after 1 hr by liquid scintillation counting,CHEMBL1156787,IC50,Cc1cn(Cc2ccc3ccccc3c2)c2c(/C=C/C(=O)NS(=O)(=O)c3cc(Cl)c(Cl)s3)cc(F)cc12,5.438064236686219
CHEMBL1081186,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,18600.0,nM,CHEMBL1101723,B,Binding affinity to human EP4 receptor by radioligand displacement assay,CHEMBL1154363,IC50,Cc1cn(Cc2ccc(Cl)cc2Cl)c2c(-c3cc(NS(=O)(=O)c4ccc(F)c(F)c4)no3)cc(F)cc12,4.730487055782084
CHEMBL1093791,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,15100.0,nM,CHEMBL1107243,B,Binding affinity to human EP4 receptor by radioligand displacement assay,CHEMBL1156157,IC50,O=C(/C=C/c1cccc2c1N(Cc1ccc3ccccc3c1)C(=O)C2O)NS(=O)(=O)c1ccc(F)cc1,4.82102305270683
CHEMBL1093792,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2300.0,nM,CHEMBL1107243,B,Binding affinity to human EP4 receptor by radioligand displacement assay,CHEMBL1156157,IC50,O=C(/C=C/c1cccc2c1N(Cc1ccc3ccccc3c1)C(=O)C2O)NS(=O)(=O)c1ccc(F)c(F)c1,5.638272163982407
CHEMBL1093125,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8700.0,nM,CHEMBL1107243,B,Binding affinity to human EP4 receptor by radioligand displacement assay,CHEMBL1156157,IC50,O=C(/C=C/c1cccc2c1N(Cc1ccc3ccccc3c1)C(=O)C2O)NS(=O)(=O)c1cc(F)c(F)cc1F,5.060480747381382
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,9.9,nM,CHEMBL1120703,B,Binding affinity to EP4 receptor,CHEMBL1155461,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.00436480540245
CHEMBL1669018,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.6,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccccc4OC)CC3)cc1C)C2,8.337242168318426
CHEMBL1669017,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.9,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ncccc4OC)CC3)cc1C)C2,8.309803919971486
CHEMBL1669016,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.8,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4cc(C(=O)O)ccc4OC)CC3)cc1C)C2,8.42021640338319
CHEMBL1669015,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6.0,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccccc4Cl)CC3)cc1C)C2,8.221848749616356
CHEMBL1669014,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.1,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccc(Cl)cc4Cl)CC3)cc1C)C2,8.67778070526608
CHEMBL1669018,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,16.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccccc4OC)CC3)cc1C)C2,7.795880017344075
CHEMBL1669017,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,23.6,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ncccc4OC)CC3)cc1C)C2,7.627087997029893
CHEMBL1669016,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,60.6,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4cc(C(=O)O)ccc4OC)CC3)cc1C)C2,7.217527375833714
CHEMBL1669015,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,35.1,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccccc4Cl)CC3)cc1C)C2,7.454692883534176
CHEMBL1669014,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10.2,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)Cc4ccc(Cl)cc4Cl)CC3)cc1C)C2,7.991399828238082
CHEMBL1669013,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.5,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(C)cc4)CC3)cc1C)C2,8.823908740944319
CHEMBL1669013,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,17.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(C)cc4)CC3)cc1C)C2,7.769551078621726
CHEMBL1669012,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.4,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4Cl)CC3)cc1C)C2,8.619788758288394
CHEMBL1669012,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,33.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4Cl)CC3)cc1C)C2,7.481486060122112
CHEMBL1669011,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.0,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,Cc1cc(CC2(NC(=O)NS(=O)(=O)c3ccccc3Cl)CC2)ccc1N1Cc2c(c(OCC(F)(F)F)c3cccnc3c2OCC(F)(F)F)C1=O,8.522878745280337
CHEMBL1669011,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,48.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,Cc1cc(CC2(NC(=O)NS(=O)(=O)c3ccccc3Cl)CC2)ccc1N1Cc2c(c(OCC(F)(F)F)c3cccnc3c2OCC(F)(F)F)C1=O,7.318758762624412
CHEMBL1669010,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.3,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4C)CC3)cc1C)C2,8.481486060122112
CHEMBL1669010,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,14.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4C)CC3)cc1C)C2,7.853871964321762
CHEMBL1669009,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.8,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4OC)CC3)cc1C)C2,8.42021640338319
CHEMBL1669009,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,23.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4OC)CC3)cc1C)C2,7.638272163982407
CHEMBL1669008,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.0,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(Cl)cccc4Cl)CC3)cc1C)C2,8.522878745280337
CHEMBL1669008,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,14.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(Cl)cccc4Cl)CC3)cc1C)C2,7.853871964321762
CHEMBL1669007,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.5,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc5ccccc5c4)CC3)cc1C)C2,8.602059991327963
CHEMBL1669007,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,37.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc5ccccc5c4)CC3)cc1C)C2,7.431798275933005
CHEMBL1669006,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.3,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4C(F)(F)F)CC3)cc1C)C2,8.481486060122112
CHEMBL1669006,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,28.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4C(F)(F)F)CC3)cc1C)C2,7.552841968657781
CHEMBL1669005,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.3,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(OC)cccc4OC)CC3)cc1C)C2,8.481486060122112
CHEMBL1669005,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,21.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(OC)cccc4OC)CC3)cc1C)C2,7.6777807052660805
CHEMBL1669004,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.2,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4Br)CC3)cc1C)C2,8.657577319177793
CHEMBL1669004,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,22.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccccc4Br)CC3)cc1C)C2,7.657577319177793
CHEMBL1669003,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8.9,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,Cc1cc(CC2(NC(=O)NS(=O)(=O)c3ccc4ccccc4c3)CC2)ccc1N1Cc2c(c(OCC(F)(F)F)c3cccnc3c2OCC(F)(F)F)C1=O,8.050609993355087
CHEMBL1669003,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,103.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,Cc1cc(CC2(NC(=O)NS(=O)(=O)c3ccc4ccccc4c3)CC2)ccc1N1Cc2c(c(OCC(F)(F)F)c3cccnc3c2OCC(F)(F)F)C1=O,6.987162775294828
CHEMBL1669002,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8.3,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)cc1C)C2,8.080921907623926
CHEMBL1669002,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,370.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(OC(F)(F)F)cc4)CC3)cc1C)C2,6.431798275933005
CHEMBL1669024,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.6,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(F)cc4)CC3)cc1C)C2,8.337242168318426
CHEMBL1669024,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,80.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4ccc(F)cc4)CC3)cc1C)C2,7.096910013008056
CHEMBL1669025,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.0,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4cccc(Cl)c4Cl)CC3)cc1C)C2,8.698970004336019
CHEMBL1669025,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,28.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4cccc(Cl)c4Cl)CC3)cc1C)C2,7.552841968657781
CHEMBL1669026,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.2,nM,CHEMBL1671179,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(C)cccc4C)CC3)cc1C)C2,8.494850021680094
CHEMBL1669026,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,19.0,nM,CHEMBL1671180,B,Displacement of [3H]PGE2 from human EP4 receptor expressed in HEK293 cells by scintillation counting in presence of 10% human serum,CHEMBL1667778,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(C)cccc4C)CC3)cc1C)C2,7.721246399047171
CHEMBL591666,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,8.0
CHEMBL1910022,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,C[C@H](NC(=O)c1cccc2c1Oc1cc(C(F)(F)F)ccc1CC2)c1ccc(C(=O)O)cc1,8.698970004336019
CHEMBL1910023,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,O=C(O)c1ccc(C2(NC(=O)c3cccc4c3Oc3cc(C(F)(F)F)ccc3CC4)CC2)cc1,8.397940008672037
CHEMBL1910024,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,63.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,C[C@H](NC(=O)c1cccc2c1Oc1ccc(C(F)(F)F)cc1CC2)c1ccc(C(=O)O)cc1,7.200659450546418
CHEMBL1910025,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,27.0,nM,CHEMBL1913308,B,Displacement of [3H]-PGE2 from human EP4 receptor expressed in HEK293 cells,CHEMBL1909549,IC50,O=C(O)c1ccc(C2(NC(=O)c3cccc4c3Oc3ccc(C(F)(F)F)cc3CC4)CC2)cc1,7.568636235841012
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.1,nM,CHEMBL2395082,B,Displacement of [3H]PGE2 from human recombinant prostanoid EP4 receptor in CHEM1 cells after 2 hrs,CHEMBL2390918,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,8.958607314841775
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.45,nM,CHEMBL2394932,B,Binding affinity to human prostanoid EP4 receptor by radioligand displacement assay,CHEMBL2390830,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,9.346787486224656
CHEMBL3115074,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,123.0,nM,CHEMBL3116956,B,Antagonist activity at EP4 receptor in human whole blood assessed as reversal of PGE2 inhibitory effect on LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS/PGE2 addition measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3112423,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,6.910094888560602
CHEMBL3260419,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1000.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,Cc1oc(C(=O)O)cc1COc1ccc(-c2ccccc2)cc1,6.0
CHEMBL3260420,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1200.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,CC(C)c1c(C(=O)O)cnn1-c1nc(-c2ccc3ccccc3c2)cs1,5.920818753952375
CHEMBL3260421,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,460.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,O=C(O)c1ccc2c(c1)C(=O)N(c1ccc3c(c1)oc1ccccc13)C2=O,6.337242168318426
CHEMBL1537470,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2600.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,O=C(Cc1cccc2ccccc12)Nc1ccccc1C(=O)O,5.585026652029182
CHEMBL3260422,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1000.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,CC(=O)c1ccc(NS(=O)(=O)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc2C)cc1,6.0
CHEMBL3260423,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4600.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,Cc1oc(C(=O)O)cc1COc1ccc2oc3ccccc3c2c1,5.337242168318426
CHEMBL3260426,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10000.0,nM,CHEMBL3266970,B,Displacement of [3H]PGE2 from human prostanoid EP4 receptor expressed in cell membranes by scintillation counting,CHEMBL3259671,IC50,Cc1oc(C(=O)O)cc1COc1cccc(-c2ccccc2)c1,5.0
CHEMBL3586359,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,18000.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,O=c1cc(CN2CCOc3c(Cl)cc(-c4csc5ccccc45)cc3C2)cc[nH]1,4.7447274948966935
CHEMBL3586353,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3200.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,Clc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.494850021680094
CHEMBL3586362,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20000.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,C[C@@H]1COc2c(Cl)cc(-n3ccc4cc(F)ccc43)cc2CN1Cc1cc[nH]c(=O)c1,4.698970004336019
CHEMBL3586361,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,30000.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,C[C@@H]1COc2c(Cl)cc(-c3csc4ccccc34)cc2CN1Cc1cc[nH]c(=O)c1,4.522878745280337
CHEMBL3586360,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,30000.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,O=c1cc(CN2CCOc3c(Cl)cc(-n4ccc5cc(F)ccc54)cc3C2)cc[nH]1,4.522878745280337
CHEMBL3586309,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3500.0,nM,CHEMBL3588433,B,Displacement of [3H]-PGE2 from human EP4 receptor overexpressed in human ECV304 cell membranes by scintillation proximity assay,CHEMBL3585259,IC50,COc1cc(-c2csc3ccccc23)cc2c1OCCN(Cc1cccnc1)C2,5.455931955649724
CHEMBL3600884,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,121.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccc(F)cc1)c1ccc(C(=O)O)cc1.Cl,6.91721462968355
CHEMBL3600883,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1209.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccc(C#N)cc1)c1ccc(C(=O)O)cc1.Cl,5.917573699139228
CHEMBL3600788,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,586.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,Cl.O=C(O)c1ccc(C2(NC(=O)[C@H]3CCCCN3CCOc3ccccc3)CC2)cc1,6.232102383981909
CHEMBL3600787,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,291.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,CC[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,6.536107011014092
CHEMBL3115074,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,126.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,6.899629454882437
CHEMBL3600786,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,899.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,Cl.O=C(O)c1ccc(CNC(=O)[C@H]2CCCCN2CCOc2ccccc2)cc1,6.046240308266771
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1614.0,nM,CHEMBL3603412,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha reduction preincubated for 30 mins followed by PGE2 addition measured after 24 hrs by ELISA,CHEMBL3600314,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,5.7920964696139485
CHEMBL3600884,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,71.8,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccc(F)cc1)c1ccc(C(=O)O)cc1.Cl,7.1438755557577
CHEMBL3600883,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,621.0,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccc(C#N)cc1)c1ccc(C(=O)O)cc1.Cl,6.20690839982342
CHEMBL3600788,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,77.8,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,Cl.O=C(O)c1ccc(C2(NC(=O)[C@H]3CCCCN3CCOc3ccccc3)CC2)cc1,7.109020403010311
CHEMBL3600787,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,232.0,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,CC[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,6.634512015109101
CHEMBL3115074,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,68.8,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,C[C@H](NC(=O)[C@H]1CCCCN1CCOc1ccccc1)c1ccc(C(=O)O)cc1.Cl,7.162411561764489
CHEMBL3600786,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,203.0,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,Cl.O=C(O)c1ccc(CNC(=O)[C@H]2CCCCN2CCOc2ccccc2)cc1,6.692503962086787
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,689.0,nM,CHEMBL3603410,B,Displacement of [3H]-PGE2 from recombinant human EP4 receptor expressed in HEK293 cell membranes after 90 mins by liquid scintillation counting analysis,CHEMBL3600314,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,6.161780778092375
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1520.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,5.818156412055227
CHEMBL3741642,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1980.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2ccccc2)nc2ccccc12,5.703334809738469
CHEMBL3739779,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,501.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2cccc(CO)c2)nc2ccccc12,6.300162274132754
CHEMBL3741902,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,312.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(CO)c2)nc2ccccc12,6.505845405981557
CHEMBL3742015,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,623.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2ccccc2)cc2ccccc12,6.20551195334083
CHEMBL3739435,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,577.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2ccccc2)cc2ccccc12,6.238824186844269
CHEMBL3741430,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,136.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2cccc(CO)c2)cc2ccccc12,6.866461091629782
CHEMBL3740223,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6.2,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(CO)c2)cc2ccccc12,8.207608310501746
CHEMBL3740325,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,243.0,nM,CHEMBL3744252,B,"Antagonist activity at EP4 receptor in human whole blood assessed as reversal of inhibition of PGE2 mediated LPS-induced TNF alpha production pretreated for 30 mins using 3,3',5,5' tetramethylbiphenyl-4,4'-diamine substrate measured after 20 to 24 hrs by immunoassay",CHEMBL3739413,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(Cl)c2)cc2ccccc12,6.614393726401688
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1600.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,5.795880017344075
CHEMBL1669008,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,78.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,CCOc1c2c(c(OCC)c3ccccc13)C(=O)N(c1ccc(CC3(NC(=O)NS(=O)(=O)c4c(Cl)cccc4Cl)CC3)cc1C)C2,7.107905397309519
CHEMBL3740223,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6.2,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(CO)c2)cc2ccccc12,8.207608310501746
CHEMBL3740325,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,243.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(Cl)c2)cc2ccccc12,6.614393726401688
CHEMBL3753274,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,59.5,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(CO)c2)cc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,7.22548303427145
CHEMBL3753133,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,72.4,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1cc(-c2cccc(CO)c2)ccc1F,7.140261433802853
CHEMBL3753860,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,18.7,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(CO)c2)cc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,7.7281583934635005
CHEMBL3753567,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,47.8,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1cc(-c2cccc(CO)c2)ccc1F,7.320572103387882
CHEMBL3754085,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,38.7,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(CO)c2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,7.412289034981089
CHEMBL3753286,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,59.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(C(=O)O)c(C)c1NC(=O)c1nc(-c2cccc(CO)c2)ccc1C(F)(F)F,7.229147988357855
CHEMBL3753835,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,56.3,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(CO)c2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,7.249491605148654
CHEMBL3752948,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,121.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1cc(C(=O)O)cc(C)c1NC(=O)c1nc(-c2cccc(CO)c2)ccc1C(F)(F)F,6.91721462968355
CHEMBL3753372,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,637.0,nM,CHEMBL3754944,B,Antagonist activity at EP4 receptor in LPS-stimulated human whole blood assessed as inhibition of PGE2-induced TNF-alpha release pretreated for 30 mins followed by addition of PGE2 measured after 20 to 24 hrs by immunoassay,CHEMBL3751833,IC50,Cc1ccc(-c2cccc(Cl)c2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,6.195860567664649
CHEMBL3686863,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,123.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCC(O)CC2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,6.910094888560602
CHEMBL3793924,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3600.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCC(C)(O)CC2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,5.443697499232712
CHEMBL3793002,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1160.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCC(F)(F)CC2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,5.935542010773082
CHEMBL3793956,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1450.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCCC(CO)C2)nc1C(=O)Nc1c(C)cc(C(=O)O)cc1C,5.838631997765026
CHEMBL3792709,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1450.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCC(O)CC2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,5.838631997765026
CHEMBL3793928,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2890.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(N2CCCC(CO)C2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,5.539102157243452
CHEMBL3754085,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,38.7,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,Cc1ccc(-c2cccc(CO)c2)nc1C(=O)Nc1c(C)ccc(C(=O)O)c1C,7.412289034981089
CHEMBL3039498,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1520.0,nM,CHEMBL3795721,B,Antagonist activity against EP4 in human whole blood assessed as reversal of PGE2-mediated suppression of LPS-induced TNF-alpha production preincubated for 30 mins followed by LPS stimulation measured after 20 to 24 hrs by enzyme immunoassay,CHEMBL3792364,IC50,CCc1nc2c(C)nc(C)cc2n1-c1ccc(CCNC(=O)NS(=O)(=O)c2ccc(C)cc2)cc1,5.818156412055227
CHEMBL548,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.55,nM,CHEMBL3876386,B,Displacement of [3H]PGE2 from human recombinant EP4 receptor expressed in HEK293 cells measured after 120 mins by scintillation counting method,CHEMBL3875185,IC50,CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,9.259637310505756
CHEMBL3939358,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,13100.0,nM,CHEMBL3883095,B,Displacement of [3H]PGE2 from from human EP4 receptor expressed in HEK293 cells membranes incubated for 60 mins,CHEMBL3882734,IC50,COC(=O)CCCCCC[C@@H]1[C@@H](c2ccc3c(c2)CCC3)[C@H](O)C[C@H]1Cl,4.882728704344236
CHEMBL3954286,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,98.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CSCCCS[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,7.008773924307505
CHEMBL3954286,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,300.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CSCCCS[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,6.522878745280337
CHEMBL3960625,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,44.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](SCCCSCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.356547323513812
CHEMBL3960625,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,29.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](SCCCSCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.537602002101044
CHEMBL3971666,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2455.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCCC#CC[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C\C(O)CCc1sc2ccccc2c1Cl,5.609948503541013
CHEMBL3950189,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,200.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C\C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,6.698970004336019
CHEMBL3950189,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,100.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C\C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.0
CHEMBL3979233,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2700.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,5.568636235841012
CHEMBL3979233,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2300.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1sc2ccccc2c1Cl,5.638272163982407
CHEMBL3955476,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,200.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,6.698970004336019
CHEMBL3955476,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2sc3ccccc3c2Cl)[C@@H]1O,7.698970004336019
CHEMBL3966610,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,400.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](CC#CCCCC(=O)O)C(=O)C(C)(C)[C@H]1O,6.3979400086720375
CHEMBL3895324,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,5.5,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C(C)(C)[C@H]1O,8.259637310505756
CHEMBL3978305,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,400.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)OC)C(=O)C(C)(C)[C@H]1O,6.3979400086720375
CHEMBL3964563,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2ccccc2)[C@@H]1O,8.397940008672037
CHEMBL3964563,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,76.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2ccccc2)[C@@H]1O,7.119186407719209
CHEMBL3986534,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,45.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1ccccc1,7.346787486224656
CHEMBL3986534,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1400.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1ccccc1,5.853871964321762
CHEMBL3928703,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2400.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1ccccc1,5.619788758288394
CHEMBL3928703,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,700.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)CCc1ccccc1,6.154901959985743
CHEMBL3946494,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,72.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2ccccc2)[C@@H]1O,7.142667503568731
CHEMBL3946494,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,59.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)CCc2ccccc2)[C@@H]1O,7.229147988357855
CHEMBL3922155,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,20.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,7.698970004336019
CHEMBL3922155,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,310.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,6.508638306165727
CHEMBL3909714,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,832.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCN(CC)C(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1cc2ccccc2s1,6.0798766737092755
CHEMBL3909714,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,478.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CCN(CC)C(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1cc2ccccc2s1,6.320572103387882
CHEMBL3896491,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4154.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(=O)NCCO)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,5.38153350780092
CHEMBL3900651,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,678.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(N)=O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,6.168770306132936
CHEMBL3900651,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,5000.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](C/C=C\CCCC(N)=O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,5.301029995663981
CHEMBL3923193,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,219.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1cc2ccccc2s1,6.6595558851598815
CHEMBL3923193,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,10000.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,COC(=O)CCC/C=C\C[C@H]1C(=O)C(C)(C)[C@@H](O)[C@@H]1/C=C/C(O)Cc1cc2ccccc2s1,5.0
CHEMBL3954031,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,256.0,nM,CHEMBL3887098,B,"Radioligand Binding: HEK-293 cells stably expressing the human or feline FP receptor, or EP1, EP2, EP3, or EP4 receptors were washed with TME buffer, scraped from the bottom of the flasks, and homogenized for 30 sec using a Brinkman PT 10/35 polytron. TME buffer was added to achieve a final 40 ml volume in the centrifuge tubes (the composition of TME is 100 mM TRIS base, 20 mM MgCl2, 2M EDTA; 10 N HCl is added to achieve a pH of 7.4).The cell homogenate was centrifuged at 19000 r.p.m. for 20 min at 4 C. using a Beckman Ti-60 rotor. The resultant pellet was resuspended in TME buffer to give a final 1 mg/ml protein concentration, as determined by Biorad assay. Radioligand binding competition assays vs. [3H-]17-phenyl PGF2 (5 nM) were performed in a 100 ul volume for 60 min. Binding reactions were started by adding plasma membrane fraction. The reaction was terminated by the addition of 4 ml ice-cold TRIS-HCl buffer and rapid filtration through glass fiber GF/B filters using a Brandel cell.",CHEMBL3886165,IC50,CC1(C)C(=O)[C@H](CC#CCCCC(=O)O)[C@@H](/C=C/C(O)Cc2cc3ccccc3s2)[C@@H]1O,6.59176003468815
CHEMBL64804,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.38,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCCCC[C@@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O,9.42021640338319
CHEMBL3982139,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.2,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,8.920818753952375
CHEMBL3918816,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1.3,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,8.886056647693163
CHEMBL3897335,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.4,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,C[C@@H](CCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,8.619788758288394
CHEMBL3955128,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.57,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCCCCC(=O)O,9.244125144327509
CHEMBL3959605,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,4.9,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,O=C(O)CCCCCCN1C(=O)C(F)(F)C[C@@H]1/C=C/[C@@H](O)CCCCc1ccccc1,8.309803919971486
CHEMBL3895047,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.32,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,9.494850021680094
CHEMBL3923027,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.22,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCc1ccc(C(=O)O)cc1,9.657577319177793
CHEMBL3949856,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,3.3,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCC#CC[C@H](C)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,8.481486060122112
CHEMBL3975743,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.74,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,C[C@@H](CCCc1ccccc1)[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,9.130768280269024
CHEMBL3916499,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.28,nM,CHEMBL3887481,B,"Radioligand Binding Assay: Assay Volume and Format:200 μl in 96-well plateCell membrane homogenates (20 μg protein) are incubated for 120 min at 22° C. with 0.5 nM [3H]PGE2 in the absence or presence of the test compound in a buffer containing 10 mM MES/KOH (pH 6.0), 10 mM MgCl2 and 1 mM EDTA.Nonspecific binding is determined in the presence of 10 M PGE2.Following incubation, the samples are filtered rapidly under vacuum through glass fiber filters (GF/B, Packard) presoaked with 0.3% PEI and rinsed several times with ice-cold 50 mM Tris-HCl using a 96-sample cell harvester (Unifilter, Packard). The filters are dried then counted for radioactivity in a scintillation counter (Topcount, Packard) using a scintillation cocktail (Microscint 0, Packard).",CHEMBL3886335,IC50,CCCCC[C@H](O)/C=C/[C@H]1CC(F)(F)C(=O)N1CCCc1ccc(C(=O)O)s1,9.55284196865778
CHEMBL4103046,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,104.0,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(F)cnc2Oc2ccc(F)cc2)cc1,6.982966660701219
CHEMBL4092846,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,124.0,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(F)ccc2Oc2ccc(F)cc2)cc1,6.906578314837764
CHEMBL4065183,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,37.9,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(Cl)cnc2Oc2ccc(F)cc2)cc1,7.421360790031928
CHEMBL4066230,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,21.6,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,O=C(O)c1ccc(CNC(=O)c2cc(Cl)ccc2Oc2ccc(F)cc2)cc1,7.665546248849069
CHEMBL4095293,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,28.7,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(F)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,7.542118103266008
CHEMBL4096216,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,9.68,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,8.014124642691606
CHEMBL591666,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,6.59,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,8.18111458540599
CHEMBL4061595,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,545.0,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,CC(C)(NC(=O)c1cc(F)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,6.2636034977233574
CHEMBL4072974,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,181.0,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,CCC(NC(=O)c1cc(F)cnc1Oc1ccc(F)cc1)c1ccc(C(=O)O)cc1,6.7423214251308154
CHEMBL4099851,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.4,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,8.619788758288394
CHEMBL4062620,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,5.02,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(Cl)c1)c1ccc(C(=O)O)cc1,8.29929628285498
CHEMBL4094572,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,13.4,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)cnc1Oc1cccc(C#N)c1)c1ccc(C(=O)O)cc1,7.872895201635192
CHEMBL4078648,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,8.76,nM,CHEMBL3997110,B,Displacement of [3H]PGE from human EP4 receptor expressed in HEK293 cell membranes,CHEMBL3994644,IC50,C[C@H](NC(=O)c1cc(Cl)ccc1Oc1cccc(F)c1)c1ccc(C(=O)O)cc1,8.05749589383192
CHEMBL4535971,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,0.4,nM,CHEMBL4380455,B,Inhibition of human EP4 transfected in human HEK293 cells co transfected with SmBit-beta-arrestin. assessed as reduction in PGE2 induced-beta-arrestin recruitment by NanoBiT beta-arrestin recruitment assay,CHEMBL4376865,IC50,C/C=C/c1nnn(Cc2ccc(C(F)(F)F)cc2)c1C(=O)N[C@@H](C)c1ccc(C(=O)O)cc1,9.397940008672037
CHEMBL4448899,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,1120.0,nM,CHEMBL5214528,B,Selectivity interaction (Eurofins-Panlabs radioligand binding assay ) EUB0000307b PTGER4,CHEMBL5212743,IC50,Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1,5.950781977329818
CHEMBL5272661,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.0,nM,CHEMBL5242761,B,Agonist activity at human EP4 receptor expressed in CHO cells co-transfected with CRE-beta-lactamase reporter gene assessed as increase in intracellular cAMP measured after 3 hrs by TR FRET based assay,CHEMBL5241102,IC50,CC(C)CC(=O)c1ccc(CCCN2C(=O)CC[C@@H]2CC[C@@H](O)Cc2cccc(C(F)(F)F)c2)s1,8.698970004336019
CHEMBL378376,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,2.0,nM,CHEMBL5242761,B,Agonist activity at human EP4 receptor expressed in CHO cells co-transfected with CRE-beta-lactamase reporter gene assessed as increase in intracellular cAMP measured after 3 hrs by TR FRET based assay,CHEMBL5241102,IC50,O=C(O)c1ccc(CCCN2C(=O)CC[C@@H]2CC[C@@H](O)Cc2cccc(C(F)(F)F)c2)s1,8.698970004336019
CHEMBL3670685,CHEMBL1836,Prostanoid EP4 receptor,IC50,=,13.5,nM,CHEMBL5321070,B,Antagonist activity at EP4 receptor (unknown origin),CHEMBL5316375,IC50,C[C@H](NC(=O)c1c(C(F)F)nn(C)c1Oc1cccc(C(F)(F)F)c1)c1ccc(C(=O)O)cc1,7.8696662315049934
